Mettler-Toledo International (MTD) — Analysis Summary
Mettler-Toledo International (MTD) has a market cap of $28.02B with year-over-year revenue growth of +4.0%. Net margin stands at 21.6%. The stock trades at a P/E ratio of 32.2.
Key Takeaways
- Revenue changed +4.0% year-over-year
- Net margin of 21.6%
- P/E ratio of 32.2
Compared to other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector, MTD posted revenue growth of +4.0% and trades at a P/E of 32.2.
Mettler-Toledo International (MTD)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at 0.0x — earnings do not cover interest payments
Shareholder equity is negative, which can signal balance-sheet stress.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
Sector
LABORATORY ANALYTICAL INSTRUMENTS
Employees
18,100
Headquarters
COLUMBUS, OH
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.